3Thomas AR, Chan LN, Bauman JL, Olopade CO. Prolongation of the QT interval related to cisapride-diltiazem interaction. Pharmacotherapy, 1998, 18: 381～385. 被引量：1
4Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N,Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther, 1997, 283:1000～1008. 被引量：1
5Yoshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn Ther, 1989, 300: 51～67. 被引量：1
6Yoshida N. Pharmacological effects of the gastroprokinetic agent mosapride citrate. Nippon Yakurigaku Zasshi,1999, 113: 299～307. 被引量：1
7Carlsson L, Amos GJ, Andersson B, Drews L, Duker G,Wadstedt G. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential? J Pharmacol Exp Ther, 1997, 282: 220～227. 被引量：1
8Kii Y, Ito T. Effects of 5-HT4-receptor agonists, cisapride,mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J Cardiovasc Pharmacol, 1997, 29: 670～675. 被引量：1
9Sakurai-Yamashita Y, Yamashita K, Kanematsu T,Taniyama K. Localization of the 5-HT4 receptor in the human and the guinea pig colon. Eur J Pharmacol, 1999,383: 281～285. 被引量：1
10Taniyama K, Makimoto N, Furuichi A, Sakurai-Yamashita Y, Nagase Y, Kaibara M, Kanematsu T. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol, 2000, 35: 575～582. 被引量：1
